Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISPR-edited CISH-knockout TILs in metastatic GI cancer
NCT04426669Phase 2Completed
- Sponsor
- Intima Bioscience
- Start
- May 2020
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of CISH-inactivated tumor-infiltrating lymphocytes in Gastrointestinal Epithelial Tumors, sponsored by Intima Bioscience. Started May 2020; status: completed.
02
Drugs
CISH-inactivated tumor-infiltrating lymphocytes
03
Conditions
Gastrointestinal Epithelial Tumors
Beyond the preview
Go deeper on NCT04426669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04426669.